The new design maintains the journal's classic look while incorporating features including an updated typeface, illustrations and graphics with a consistent style, and more color throughout.
"The Leading Edge section will feature in-depth analytical articles by science writers, and essays and commentaries by eminent scientists," Cell Editor Emilie Marcus explains. "In a time of increasing scientific specialization, we feel a responsibility to support the progress of science by promoting interdisciplinary communication. All of our content and design changes will support these goals while maintaining Cell's reputation for high standards of research and communicating conceptual scientific advances."
The changes debut in the December 2, 2005 issue, which is freely available online, at www.cell.com/content/issue?volume=123&issue=5.
About Cell Press: Cell Press (www.CellPress.com) an imprint of Elsevier, is committed to improving scientific communication through the publication of exciting biology research and reviews. Cell Press journals include the flagship journal Cell (www.cell.com), Neuron (www.neuron.org), Immunity (www.immunity.com), Molecular Cell (www.molecule.org), Developmental Cell (www.developmentalcell.com), Cancer Cell (www.cancercell.org), Current Biology (www.current-biology.com), Structure (www.structure.org), Chemistry & Biology (www.chembiol.com), and the new journal Cell Metabolism (www.cellmetabolism.org), which launched in January 2005. Cell Press's mission is to continue to publish and develop journals that deliver the highest possible intellectual rigor, promote community trust, and are widely disseminated.
About Elsevier: Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in 71 offices worldwide publish more than 2,000 journals and 2,200 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect ,MD Consult, Scopus, bibliographic databases, and online reference works.
Elsevier (elsevier.com) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (reedelsevier.com), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).